In this issue:
Prostate Cancer Awareness Month
Active surveillance and watchful waiting
Prostate cancer trials in Australia
Managing nmCRPC
Diagnosing and treating post-prostatectomy urinary incontinence
Therapy resistance in prostate cancer
Meeting your professional obligations when using AI in healthcare
TGA approves the first targeted nuclear medicine
Release of stage 3 for 60-day prescriptions
591-day delay for new medicines
Bacterial infections
BINS 4 Blokes 2024
Olaparib may be effective without hormone therapy
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)